Katharina Wolf
23.05.2017
Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
Waizel M, Todorova M, Masyk M, Wolf K, Rickmann A, Helaiwa K, Blanke B, Szurman P. Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD. BMC Ophthalmol 2017; 17:79.
23.05.2017Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD
23.05.2017BMC Ophthalmol 2017; 17:79
Waizel Maria, Todorova Margarita, Masyk Michael, Wolf Katharina, Rickmann Annekatrin, Helaiwa Khaled, Blanke Björn R., Szurman Peter
Weiter
04.08.2016
Author's reply to comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD
Waizel M, Kazerounian S, Rickmann A, Wolf K, Blanke B, Todorova M. Author's reply to comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD. Eur J Ophthalmol 2016; 26:e139-40.
04.08.2016Author's reply to comments to: Response to bevacizumab after treatment with aflibercept in eyes with neovascular AMD
04.08.2016Eur J Ophthalmol 2016; 26:e139-40
Waizel Maria, Kazerounian Sara, Rickmann Annekatrin, Wolf Katharina, Blanke Björn R., Todorova Margarita
Weiter